Veraxa Biotech is trading 10.19% up in pre-market at $1.19 on October 7, 2026, compared with its October 6 close of $1.08; no confirmed company-specific catalyst has surfaced. - The investor-relations news page lists the September 4 CFO appointment as its latest release; no October 7 announcement is shown. - Broad market futures are lower and do not clearly explain the move; the cause remains uncertain.